Ursodiol, also known by its trade names Actigall, Urso, Urso Forte, and others, is a bile acid used primarily to dissolve
gallstones and to treat
primary biliary cholangitis (PBC), a type of liver disease. It has garnered significant attention in both clinical and research settings for its unique therapeutic properties. Ursodiol is produced and marketed by various pharmaceutical companies worldwide, including but not limited to
Allergan,
Zydus Pharmaceuticals, and
Lannett Company. The drug has emerged as a non-surgical option for patients with specific gallbladder issues and liver conditions, thus minimizing the need for invasive procedures.
The primary targets for Ursodiol are the liver and gallbladder. It is particularly effective in dissolving cholesterol-laden gallstones and improving liver function in patients with PBC. Research institutions and hospitals around the globe have conducted extensive studies to understand the full spectrum of Ursodiol's efficacy, mechanisms, and safety profiles. Its clinical indications are well-documented and include the dissolution of cholesterol gallstones in patients who either cannot undergo surgery or prefer an alternative treatment. Ursodiol is also used in the treatment of PBC to slow disease progression and improve liver function.
Ursodiol's mechanism of action involves several biochemical pathways. Primarily, it works by reducing the cholesterol content of bile and bile stones by suppressing the liver’s production of cholesterol and by inhibiting its absorption in the intestines. Ursodiol also has a cytoprotective effect on the liver cells, which helps in reducing
liver inflammation and
fibrosis in patients with PBC. It achieves this by stabilizing the hepatic cell membranes and reducing the secretion of toxic bile acids. By essentially altering the composition of bile and stabilizing cell membranes, Ursodiol helps to prevent the formation of new gallstones while dissolving existing ones. This dual action makes it a particularly effective treatment option for patients with cholesterol gallstones and certain
liver diseases.
The administration of Ursodiol is relatively straightforward but requires adherence to specific guidelines for optimal effectiveness. It is typically administered orally in the form of tablets or capsules. The dosage varies depending on the condition being treated. For gallstone dissolution, the usual dosage is about 8-10 mg/kg/day, divided into two or three doses. For treating PBC, the dosage is generally around 13-15 mg/kg/day, also divided into multiple doses. The onset of action can vary; for gallstone dissolution, it may take several months to notice significant changes, whereas in PBC, improvements in liver function tests might be evident within a few weeks to months. It is imperative to follow the prescribed dosage and not to discontinue the medication abruptly, as this can lead to the recurrence of symptoms or worsening of the condition.
Like any medication, Ursodiol is not without its side effects. Fortunately, most side effects are mild and manageable. Common side effects include
diarrhea,
constipation,
nausea, and
abdominal pain. Less commonly, patients may experience
dizziness,
headache,
and back pain. Serious side effects are rare but can include severe
allergic reactions, signs of liver problems like
jaundice or dark urine, and severe abdominal pain. It is crucial to consult a healthcare provider immediately if any severe side effects are experienced.
There are also certain contraindications for the use of Ursodiol. It should not be used in patients with
complete biliary obstruction as it will not be effective and could potentially worsen the condition. Individuals with known hypersensitivity to Ursodiol or any of its components should avoid the drug. Additionally, caution should be exercised when prescribing Ursodiol to patients with liver disease or other serious health conditions. Regular monitoring of liver function tests is recommended to ensure that the drug is not adversely affecting the liver.
Several other drugs can interact with Ursodiol, potentially impacting its effectiveness or increasing the risk of side effects. For instance,
cholestyramine and
colestipol, both cholesterol-lowering medications, can bind to Ursodiol in the intestines and reduce its absorption, thereby decreasing its effectiveness. Antacids containing aluminum may also interfere with Ursodiol's absorption.
Estrogen and oral contraceptives can increase bile cholesterol levels, potentially counteracting the benefits of Ursodiol. Similarly, drugs that affect liver enzymes, such as
cyclosporine, can alter Ursodiol’s metabolism, affecting its efficacy and safety.
In conclusion, Ursodiol serves as a valuable therapeutic option for patients dealing with cholesterol gallstones and primary biliary cholangitis. Its ability to dissolve gallstones and improve liver function makes it a less invasive alternative to surgery for many individuals. While generally well-tolerated, it is important to be aware of potential side effects, contraindications, and drug interactions. Continuous research and clinical studies aim to further elucidate its full potential and optimize its use in various hepatic and biliary conditions. As always, it is essential to consult healthcare providers for personalized medical advice and to ensure that Ursodiol is used safely and effectively.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


